Orchard Therapeutics

Orchard nears FDA decision on rare disease gene therapy
Orchard nears FDA decision on rare disease gene therapy
BioPharma Dive
Orchard Therapeutics
gene therapy
metachromatic leukodystrophy
FDA
Flag link:
ASH 2022 – Orchard gets a Sanfilippo boost
ASH 2022 – Orchard gets a Sanfilippo boost
EP Vantage
ASH 2022
Orchard Therapeutics
Sanfillipo Syndrome
gene therapies
OTL-201
Flag link:
Workforce Cuts Abound at Zealand Pharma, Merck and Orchard
Workforce Cuts Abound at Zealand Pharma, Merck and Orchard
BioSpace
Zealand Pharma
Merck
Orchard Therapeutics
layoffs
Flag link:
Orchard abandons promising gene therapy for rare immune disorder
Orchard abandons promising gene therapy for rare immune disorder
BioPharma Dive
Orchard Therapeutics
gene therapy
Flag link:
The "Rare Disease Company Coalition" Launches to Share the Unique Challenges and Promise of Rare Disease Therapy Development to Support Continued Progress and Patient Access
The "Rare Disease Company Coalition" Launches to Share the Unique Challenges and Promise of Rare Disease Therapy Development to Support Continued Progress and Patient Access
Yahoo/Businesswire
Rare Diseases
Rare Disease Company Coalition
drug development
drug discovery
Acceleron
Aeglea BioTherapeutics
Agios Pharmaceuticals
Alnylam
Harmony Biosciences
Orchard Therapeutics
Orphazyme
Sarepta Therapeutics
Taysha Gene Therapies
Ultragenyx
Flag link:
Orchard licenses gene therapy tech from GSK
Orchard licenses gene therapy tech from GSK
Fierce Biotech
Orchard Therapeutics
GSK
stem cells
gene therapy
Flag link:
Orchard lays off a quarter of its staff amid major shift
Orchard lays off a quarter of its staff amid major shift
BioPharma Dive
Orchard Therapeutics
gene therapy
layoffs
Flag link:
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Regeneron
Sanofi
Praluent
FDA
Heron Therapeutics
HTX-011
Nabiva
Orchard Therapeutics
Akari Therapeutics
Aldeyra Therapeutics
BioTime
Audentes Therapeutics
Adaptimmune
GW Pharma
Ionis
Biogen
Ovid Therapeutics
TransMedics
IPOs
Trevi Therapeutics
Flag link:
Orchard Therapeutics proposes IPO
Orchard Therapeutics proposes IPO
BioCentury
Orchard Therapeutics
IPOs
Flag link:
GSK slims portfolio with sale of rare disease gene therapy drugs
GSK slims portfolio with sale of rare disease gene therapy drugs
Yahoo/Reuters
GSK
Orchard Therapeutics
gene therapy
Rare Diseases
Flag link:
Tiny U.K. Biotech Takes On Glaxo’s $730,000 Gene Therapy
Tiny U.K. Biotech Takes On Glaxo’s $730,000 Gene Therapy
Bloomberg
gene therapy
bubble boy syndrome
GSK
Strimvelis
Orchard Therapeutics
OTL-101
Flag link:
In gene therapy’s second big win this week, Orchard nabs $110M Series B
In gene therapy’s second big win this week, Orchard nabs $110M Series B
Endpoints
gene therapy
Orchard Therapeutics
OTL-101
bubble boy syndrome
Flag link: